[HTML][HTML] WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
J Lan, B Xu, X Shi, Q Pan, Q Tao - Cellular & Molecular Biology Letters, 2022 - Springer
Background Diabetic nephropathy (DN) is prevalent in patients with diabetes. N 6-
methyladenosine (m6A) methylation has been found to cause modification of nucleotide …
methyladenosine (m6A) methylation has been found to cause modification of nucleotide …
WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy.
J Lan, B Xu, X Shi, Q Pan… - Cellular & Molecular …, 2022 - search.ebscohost.com
Background: Diabetic nephropathy (DN) is prevalent in patients with diabetes. N< sup> 6-
methyladenosine (m< sup> 6 A) methylation has been found to cause modification of …
methyladenosine (m< sup> 6 A) methylation has been found to cause modification of …
WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
J Lan, B Xu, X Shi, Q Pan… - Cellular & molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Diabetic nephropathy (DN) is prevalent in patients with diabetes. N 6-
methyladenosine (m 6 A) methylation has been found to cause modification of nucleotide …
methyladenosine (m 6 A) methylation has been found to cause modification of nucleotide …
[HTML][HTML] WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
J Lan, B Xu, X Shi, Q Pan… - Cellular & Molecular …, 2022 - cmbl.biomedcentral.com
Diabetic nephropathy (DN) is prevalent in patients with diabetes. N6-methyladenosine
(m6A) methylation has been found to cause modification of nucleotide-binding …
(m6A) methylation has been found to cause modification of nucleotide-binding …
[HTML][HTML] WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
J Lan, B Xu, X Shi, Q Pan, Q Tao - Cellular & Molecular Biology …, 2022 - ncbi.nlm.nih.gov
Background Diabetic nephropathy (DN) is prevalent in patients with diabetes. N 6-
methyladenosine (m 6 A) methylation has been found to cause modification of nucleotide …
methyladenosine (m 6 A) methylation has been found to cause modification of nucleotide …
WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy.
J Lan, B Xu, X Shi, Q Pan, Q Tao - Cellular & Molecular Biology …, 2022 - europepmc.org
Background Diabetic nephropathy (DN) is prevalent in patients with diabetes. N 6-
methyladenosine (m 6 A) methylation has been found to cause modification of nucleotide …
methyladenosine (m 6 A) methylation has been found to cause modification of nucleotide …
[PDF][PDF] WTAP‑mediated N 6‑methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
J Lan, B Xu, X Shi, Q Pan, Q Tao - 2022 - cmbl.biomedcentral.com
Background Diabetic nephropathy (DN) is one of the most severe prevalent diseases in the
modern world with a high morbidity rate [1]. 20 to 30% of diabetic patients have DN in type 1 …
modern world with a high morbidity rate [1]. 20 to 30% of diabetic patients have DN in type 1 …